Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alessia Fiorino
Observed names:
A. Fiorino,
Fiorino, Alessia
Institution:
University of Palermo
Observed institution:
University of Palermo
OpenAlex ID:
A5111413038
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes
2021
·
Luigi Magrin
, Daniele Fanale
, et al.
·
Oncogene
·
80
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge
2021
·
M. Bono
, D. Fanale
, et al.
·
ESMO Open
·
74
PDF
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients
2020
·
Lorena Incorvaia
, Daniele Fanale
, et al.
·
Therapeutic Advances in Medical Oncology
·
71
PDF
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2
2020
·
Daniele Fanale
, Lorena Incorvaia
, et al.
·
Cancers
·
63
PDF
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer
2022
·
Daniele Fanale
, Alessandra Dimino
, et al.
·
Cancers
·
60
PDF
Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes
2020
·
Lorena Incorvaia
, Daniele Fanale
, et al.
·
Cancers
·
47
PDF
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
2022
·
Daniele Fanale
, Lidia Rita Corsini
, et al.
·
Critical Reviews in Oncology/Hematology
·
41
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
2021
·
Daniele Fanale
, Alessia Fiorino
, et al.
·
Frontiers in Oncology
·
31
PDF
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning
2022
·
Daniele Fanale
, Alessia Pivetti
, et al.
·
Critical Reviews in Oncology/Hematology
·
23
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength
2022
·
Daniele Fanale
, Lidia Rita Corsini
, et al.
·
Frontiers in Oncology
·
21
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay
2023
·
Lorena Incorvaia
, Gaetana Rinaldi
, et al.
·
Therapeutic Advances in Medical Oncology
·
19
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs)
2021
·
Lorena Incorvaia
, Giuseppe Badalamenti
, et al.
·
Therapeutic Advances in Medical Oncology
·
17
PDF
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?
2023
·
Daniele Fanale
, Lidia Rita Corsini
, et al.
·
Critical Reviews in Oncology/Hematology
·
15
PDF
122P Can circulating PD-1, PD-L1, pan-BTN3As, BTN3A1, BTN2A1 and BTLA levels enhance prognostic power of serum CA125 in patients with advanced high-grade serous ovarian cancer?
2022
·
L.R. Corsini
, D. Fanale
, et al.
·
Annals of Oncology
·
3
247P Population-based testing for hereditary breast and ovarian cancer in a cohort of 1,346 patients from Southern Italy (Sicily): When historical background affects genetics
2020
·
D. Fanale
, L. Incorvaia
, et al.
·
Annals of Oncology
·
3
PDF
Heart toxicity effects (HTE) of anthracyclines-containing regimens (ACRs) in patients with breast cancer (BC) carrying mutational signature of homologous recombination deficiency (HRD).
2022
·
Lorena Incorvaia
, Alessia Fiorino
, et al.
·
Journal of Clinical Oncology
·
2
904MO Anthracycline-related cardiotoxicity in breast cancer patients carrying mutational signature of homologous recombination deficiency (HRD)
2022
·
L. Incorvaia
, A. Fiorino
, et al.
·
Annals of Oncology
·
1
32P Can circulating immune checkpoints and KIT exon 11 mutations be prognostic factors in metastatic gastrointestinal stromal tumors?
2021
·
C. Brando
, D. Fanale
, et al.
·
Annals of Oncology
·
1
1535P Exploring the dynamic crosstalk between immune system and genetics in a cohort of 116 completely resected gastrointestinal stromal tumors (GISTs)
2021
·
L. Incorvaia
, G. Badalamenti
, et al.
·
Annals of Oncology
·
1
PDF
738P Soluble PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTN2A1 as predictive biomarkers of nivolumab response in patients with metastatic clear cell renal carcinoma
2020
·
L. Incorvaia
, D. Fanale
, et al.
·
Annals of Oncology
·
1
PDF
598P Can circulating PD-L1 levels, age at diagnosis and peritoneal carcinomatosis act as survival predictors in patients with advanced high-grade serous ovarian cancer?
2022
·
D. Fanale
, C. Brando
, et al.
·
Annals of Oncology
P-264 The molecular-metabolic interplay in metastatic gastrointestinal stromal tumors (GISTs): The predictive role of body mass index
2022
·
L. Incorvaia
, C. Brando
, et al.
·
Annals of Oncology
162P Prevalence and spectrum analysis of germline BRCA1 and BRCA2 variants of unclear significance in HBOC Syndrome: Decoding the mysterious signals of the genome
2021
·
A. Fiorino
, D. Fanale
, et al.
·
Annals of Oncology
167P Role of the multi-gene panel testing for detection of pathogenic variants in patients with hereditary bilateral breast cancer
2021
·
C. Filorizzo
, D. Fanale
, et al.
·
Annals of Oncology
166P Hereditary breast, ovarian and pancreatic cancers: Looking beyond the BRCA1/2 genes
2021
·
M. Bono
, D. Fanale
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
33
Citation count:
575
H-index:
13
I10-index:
13
Year
Topic
Type